+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Patient Simulator Market Size, Share & Industry Trends Analysis Report By Type, By End User, By Technology (Low-fidelity Simulators, Medium-fidelity Simulators, and High-fidelity Simulators), By Regional Outlook and Forecast, 2023 - 2029

  • PDF Icon

    Report

  • 192 Pages
  • May 2023
  • Region: Global
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5833624
The Global Patient Simulator Market size is expected to reach $903.6 million by 2029, rising at a market growth of 8.3% CAGR during the forecast period.

Asia Pacific is one of the developing regions that focuses more on advanced and innovative technologies thereby patient simulators companies are expecting tremendous development prospects from emerging countries like India, China, and Japan. Thus, APAC is expected to generate 2/5thshare of the market by 2029. India and China have the largest patient bases and more than half the world's population. The main factors influencing the market growth in these nations are the expanding economies, increasing private investments, the untapped rural sector, the rising prevalence of non-communicable lifestyle-related diseases, the growing emphasis on medical education, training, and research, and the rising number of academic medical institutions. Some of the factors impacting the market are the rapid increase in patient simulator technology, increased attention to patient safety, and medical simulators with poor design.



With the emergence of technologies like virtual reality, artificial intelligence, robotics, augmented reality, 3D printing, and nanotechnology over the past few decades, healthcare technology has advanced quickly. These technologies will continue to shape the future of healthcare in the years to come. Manikins can now incorporate computer software because of the advancements in technology. The expanded use of simulation-based training and certification of healthcare personnel can improve patient safety and outcomes. Patient safety as a medical subspecialty came into being as a response to the increasing complication of healthcare systems and the subsequent rise in patient injuries in healthcare facilities. It prevents and minimizes risks, mistakes, and patient harm during healthcare delivery.

The COVID-19 outbreak contributed to the expansion of the market. This is attributable to the incorporation of simulators in medical training, which has created new simulators that permit more flexible and remote training. In addition, according to a National Library of Medicine article, medical school administrators and various government organizations invested in simulation-based educational management technologies and products in 2020 to maintain clinical education and competency assessment throughout the COVID-19 pandemic. Therefore, COVID-19 had a positive impact on the market.

However, models and instruments cannot accurately reflect human functioning because of how complicated human systems are. Facilitators and simulation engineers must build and modify the simulation models to accurately represent a physiological response sought under particular conditions. It can be difficult to manipulate these systems to achieve the necessary simulation aims. These elements are expected to limit the market growth.

End-user Outlook

By end user, the market is fragmented into hospital, and academic institutions. The academic institutions segment procured a significant revenue share in the market in 2022. This is due to the presence of several academic research groups engaged in studying complex biological systems utilizing computer models; the academic research institutions segment is expected to continue to expand. Medical simulation enables the acquisition of clinical skills through deliberate practice instead of apprenticeship-style instruction. Simulation tools substitute for actual patients while providing them with real-life settings to study and practice, which will fuel the segment's growth.



Product Type Outlook

On the basis of product type, the market is bifurcated into adult patient simulator, infant simulator, and childbirth simulator. The adult patient simulator segment witnessed the largest revenue share in the market in 2022. This is due to the fact that an adult patient simulator (APS) is a sophisticated medical simulation system created to give healthcare practitioners a realistic, interactive healthcare experience. It allows students to develop their clinical abilities in a secure setting by simulating a variety of medical settings and patient circumstances. APS is a crucial tool for medical education because it enables practitioners to obtain experience in various clinical settings, including ERs, ORs, and outpatient clinics, propelling the segment's growth.

Technology Outlook

Based on technology, the market is segmented into high-fidelity simulators, medium-fidelity simulators, and low-fidelity simulators. The low-fidelity simulators segment dominated the market with maximum revenue share in 2022. This is because simulators with low fidelity are used to develop knowledge. These may comprise two-dimensional displays and static models. In addition, there are task trainers like IV arms or CPR manikins that are created for particular tasks or procedures. Students have the chance to practice lung, heart, and stomach auscultation using low-fidelity simulation, which is anticipated to propel the segment's expansion in the projected period.

Regional Outlook

Region wise, the market is analyzed across North America, Europe, Asia Pacific and LAMEA. The North America region registered the highest revenue share in the market in 2022. This growth is due to several factors, including the rising demand for healthcare services, growing recognition of the use of simulation in healthcare education, and the expansion of high-tech patient simulators. The region's rising need for healthcare services will fuel market expansion. Increased demand for patient simulators and healthcare services results from the rising prevalence of chronic diseases like cardiovascular and respiratory illnesses.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Laerdal Medical Limited, CAE Inc., Gaumard Scientific Company, Inc., Kyoto Kagaku Co., Ltd., Medical-X, K.K. MedVision, Simulab Corporation, Limbs & Things Limited, Surgical Science Sweden AB, and Mentice AB.

Scope of the Study

By Type

  • Adult Patient Simulator
  • Infant Simulator
  • Childbirth Simulator

By End-user

  • Hospitals
  • Academic Institutions

By Technology

  • Low-fidelity Simulators
  • Medium-fidelity Simulators
  • High-fidelity Simulators

By Geography

  • North America
  • US
  • Canada
  • Mexico
  • Rest of North America
  • Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
  • LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

  • Laerdal Medical Limited
  • CAE Inc.
  • Gaumard Scientific Company, Inc.
  • Kyoto Kagaku Co., Ltd.
  • Medical-X
  • K.K. MedVision
  • Simulab Corporation
  • Limbs & Things Limited
  • Surgical Science Sweden AB
  • Mentice AB

Unique Offerings

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Patient Simulator Market, by Type
1.4.2 Global Patient Simulator Market, by End-user
1.4.3 Global Patient Simulator Market, by Technology
1.4.4 Global Patient Simulator Market, by Geography
1.5 Research Methodology
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Global Patient Simulator Market by Type
3.1 Global Adult Patient Simulator Market by Region
3.2 Global Infant Simulator Market by Region
3.3 Global Childbirth Simulator Market by Region
Chapter 4. Global Patient Simulator Market by End-user
4.1 Global Hospitals Market by Region
4.2 Global Academic Institutions Market by Region
Chapter 5. Global Patient Simulator Market by Technology
5.1 Global Low-fidelity Simulators Market by Region
5.2 Global Medium-fidelity Simulators Market by Region
5.3 Global High-fidelity Simulators Market by Region
Chapter 6. Global Patient Simulator Market by Region
6.1 North America Patient Simulator Market
6.1.1 North America Patient Simulator Market by Type
6.1.1.1 North America Adult Patient Simulator Market by Country
6.1.1.2 North America Infant Simulator Market by Country
6.1.1.3 North America Childbirth Simulator Market by Country
6.1.2 North America Patient Simulator Market by End-user
6.1.2.1 North America Hospitals Market by Country
6.1.2.2 North America Academic Institutions Market by Country
6.1.3 North America Patient Simulator Market by Technology
6.1.3.1 North America Low-fidelity Simulators Market by Country
6.1.3.2 North America Medium-fidelity Simulators Market by Country
6.1.3.3 North America High-fidelity Simulators Market by Country
6.1.4 North America Patient Simulator Market by Country
6.1.4.1 US Patient Simulator Market
6.1.4.1.1 US Patient Simulator Market by Type
6.1.4.1.2 US Patient Simulator Market by End-user
6.1.4.1.3 US Patient Simulator Market by Technology
6.1.4.2 Canada Patient Simulator Market
6.1.4.2.1 Canada Patient Simulator Market by Type
6.1.4.2.2 Canada Patient Simulator Market by End-user
6.1.4.2.3 Canada Patient Simulator Market by Technology
6.1.4.3 Mexico Patient Simulator Market
6.1.4.3.1 Mexico Patient Simulator Market by Type
6.1.4.3.2 Mexico Patient Simulator Market by End-user
6.1.4.3.3 Mexico Patient Simulator Market by Technology
6.1.4.4 Rest of North America Patient Simulator Market
6.1.4.4.1 Rest of North America Patient Simulator Market by Type
6.1.4.4.2 Rest of North America Patient Simulator Market by End-user
6.1.4.4.3 Rest of North America Patient Simulator Market by Technology
6.2 Europe Patient Simulator Market
6.2.1 Europe Patient Simulator Market by Type
6.2.1.1 Europe Adult Patient Simulator Market by Country
6.2.1.2 Europe Infant Simulator Market by Country
6.2.1.3 Europe Childbirth Simulator Market by Country
6.2.2 Europe Patient Simulator Market by End-user
6.2.2.1 Europe Hospitals Market by Country
6.2.2.2 Europe Academic Institutions Market by Country
6.2.3 Europe Patient Simulator Market by Technology
6.2.3.1 Europe Low-fidelity Simulators Market by Country
6.2.3.2 Europe Medium-fidelity Simulators Market by Country
6.2.3.3 Europe High-fidelity Simulators Market by Country
6.2.4 Europe Patient Simulator Market by Country
6.2.4.1 Germany Patient Simulator Market
6.2.4.1.1 Germany Patient Simulator Market by Type
6.2.4.1.2 Germany Patient Simulator Market by End-user
6.2.4.1.3 Germany Patient Simulator Market by Technology
6.2.4.2 UK Patient Simulator Market
6.2.4.2.1 UK Patient Simulator Market by Type
6.2.4.2.2 UK Patient Simulator Market by End-user
6.2.4.2.3 UK Patient Simulator Market by Technology
6.2.4.3 France Patient Simulator Market
6.2.4.3.1 France Patient Simulator Market by Type
6.2.4.3.2 France Patient Simulator Market by End-user
6.2.4.3.3 France Patient Simulator Market by Technology
6.2.4.4 Russia Patient Simulator Market
6.2.4.4.1 Russia Patient Simulator Market by Type
6.2.4.4.2 Russia Patient Simulator Market by End-user
6.2.4.4.3 Russia Patient Simulator Market by Technology
6.2.4.5 Spain Patient Simulator Market
6.2.4.5.1 Spain Patient Simulator Market by Type
6.2.4.5.2 Spain Patient Simulator Market by End-user
6.2.4.5.3 Spain Patient Simulator Market by Technology
6.2.4.6 Italy Patient Simulator Market
6.2.4.6.1 Italy Patient Simulator Market by Type
6.2.4.6.2 Italy Patient Simulator Market by End-user
6.2.4.6.3 Italy Patient Simulator Market by Technology
6.2.4.7 Rest of Europe Patient Simulator Market
6.2.4.7.1 Rest of Europe Patient Simulator Market by Type
6.2.4.7.2 Rest of Europe Patient Simulator Market by End-user
6.2.4.7.3 Rest of Europe Patient Simulator Market by Technology
6.3 Asia Pacific Patient Simulator Market
6.3.1 Asia Pacific Patient Simulator Market by Type
6.3.1.1 Asia Pacific Adult Patient Simulator Market by Country
6.3.1.2 Asia Pacific Infant Simulator Market by Country
6.3.1.3 Asia Pacific Childbirth Simulator Market by Country
6.3.2 Asia Pacific Patient Simulator Market by End-user
6.3.2.1 Asia Pacific Hospitals Market by Country
6.3.2.2 Asia Pacific Academic Institutions Market by Country
6.3.3 Asia Pacific Patient Simulator Market by Technology
6.3.3.1 Asia Pacific Low-fidelity Simulators Market by Country
6.3.3.2 Asia Pacific Medium-fidelity Simulators Market by Country
6.3.3.3 Asia Pacific High-fidelity Simulators Market by Country
6.3.4 Asia Pacific Patient Simulator Market by Country
6.3.4.1 China Patient Simulator Market
6.3.4.1.1 China Patient Simulator Market by Type
6.3.4.1.2 China Patient Simulator Market by End-user
6.3.4.1.3 China Patient Simulator Market by Technology
6.3.4.2 Japan Patient Simulator Market
6.3.4.2.1 Japan Patient Simulator Market by Type
6.3.4.2.2 Japan Patient Simulator Market by End-user
6.3.4.2.3 Japan Patient Simulator Market by Technology
6.3.4.3 India Patient Simulator Market
6.3.4.3.1 India Patient Simulator Market by Type
6.3.4.3.2 India Patient Simulator Market by End-user
6.3.4.3.3 India Patient Simulator Market by Technology
6.3.4.4 South Korea Patient Simulator Market
6.3.4.4.1 South Korea Patient Simulator Market by Type
6.3.4.4.2 South Korea Patient Simulator Market by End-user
6.3.4.4.3 South Korea Patient Simulator Market by Technology
6.3.4.5 Singapore Patient Simulator Market
6.3.4.5.1 Singapore Patient Simulator Market by Type
6.3.4.5.2 Singapore Patient Simulator Market by End-user
6.3.4.5.3 Singapore Patient Simulator Market by Technology
6.3.4.6 Malaysia Patient Simulator Market
6.3.4.6.1 Malaysia Patient Simulator Market by Type
6.3.4.6.2 Malaysia Patient Simulator Market by End-user
6.3.4.6.3 Malaysia Patient Simulator Market by Technology
6.3.4.7 Rest of Asia Pacific Patient Simulator Market
6.3.4.7.1 Rest of Asia Pacific Patient Simulator Market by Type
6.3.4.7.2 Rest of Asia Pacific Patient Simulator Market by End-user
6.3.4.7.3 Rest of Asia Pacific Patient Simulator Market by Technology
6.4 LAMEA Patient Simulator Market
6.4.1 LAMEA Patient Simulator Market by Type
6.4.1.1 LAMEA Adult Patient Simulator Market by Country
6.4.1.2 LAMEA Infant Simulator Market by Country
6.4.1.3 LAMEA Childbirth Simulator Market by Country
6.4.2 LAMEA Patient Simulator Market by End-user
6.4.2.1 LAMEA Hospitals Market by Country
6.4.2.2 LAMEA Academic Institutions Market by Country
6.4.3 LAMEA Patient Simulator Market by Technology
6.4.3.1 LAMEA Low-fidelity Simulators Market by Country
6.4.3.2 LAMEA Medium-fidelity Simulators Market by Country
6.4.3.3 LAMEA High-fidelity Simulators Market by Country
6.4.4 LAMEA Patient Simulator Market by Country
6.4.4.1 Brazil Patient Simulator Market
6.4.4.1.1 Brazil Patient Simulator Market by Type
6.4.4.1.2 Brazil Patient Simulator Market by End-user
6.4.4.1.3 Brazil Patient Simulator Market by Technology
6.4.4.2 Argentina Patient Simulator Market
6.4.4.2.1 Argentina Patient Simulator Market by Type
6.4.4.2.2 Argentina Patient Simulator Market by End-user
6.4.4.2.3 Argentina Patient Simulator Market by Technology
6.4.4.3 UAE Patient Simulator Market
6.4.4.3.1 UAE Patient Simulator Market by Type
6.4.4.3.2 UAE Patient Simulator Market by End-user
6.4.4.3.3 UAE Patient Simulator Market by Technology
6.4.4.4 Saudi Arabia Patient Simulator Market
6.4.4.4.1 Saudi Arabia Patient Simulator Market by Type
6.4.4.4.2 Saudi Arabia Patient Simulator Market by End-user
6.4.4.4.3 Saudi Arabia Patient Simulator Market by Technology
6.4.4.5 South Africa Patient Simulator Market
6.4.4.5.1 South Africa Patient Simulator Market by Type
6.4.4.5.2 South Africa Patient Simulator Market by End-user
6.4.4.5.3 South Africa Patient Simulator Market by Technology
6.4.4.6 Nigeria Patient Simulator Market
6.4.4.6.1 Nigeria Patient Simulator Market by Type
6.4.4.6.2 Nigeria Patient Simulator Market by End-user
6.4.4.6.3 Nigeria Patient Simulator Market by Technology
6.4.4.7 Rest of LAMEA Patient Simulator Market
6.4.4.7.1 Rest of LAMEA Patient Simulator Market by Type
6.4.4.7.2 Rest of LAMEA Patient Simulator Market by End-user
6.4.4.7.3 Rest of LAMEA Patient Simulator Market by Technology
Chapter 7. Company Profiles
7.1 Laerdal Medical Limited
7.1.1 Company Overview
7.1.2 Recent Strategies and Developments
7.1.2.1 Partnerships, Collaborations, and Agreements
7.1.2.2 Acquisition and Mergers
7.2 CAE Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent Strategies and Developments
7.2.5.1 Partnerships, Collaborations, and Agreements
7.2.5.2 Product Launches and Product Expansions
7.3 Gaumard Scientific Company, Inc.
7.3.1 Company Overview
7.3.2 Recent Strategies and Developments
7.3.2.1 Product Launches and Product Expansions
7.4 Kyoto Kagaku Co., Ltd.
7.4.1 Company Overview
7.5 Medical-X
7.5.1 Company Overview
7.6 K.K. MedVision
7.6.1 Company Overview
7.7 Simulab Corporation
7.7.1 Company Overview
7.8 Limbs & Things Limited
7.8.1 Company Overview
7.8.2 Recent Strategies and Developments
7.8.2.1 Partnerships, Collaborations, and Agreements
7.9 Surgical Science Sweden AB
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expenses
7.9.5 Recent Strategies and Developments
7.9.5.1 Partnerships, Collaborations, and Agreements
7.9.5.2 Acquisition and Mergers
7.1 Mentice AB
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expenses
7.10.5 Recent Strategies and Developments
7.10.5.1 Acquisition and Mergers

Companies Mentioned

  • Laerdal Medical Limited
  • CAE Inc.
  • Gaumard Scientific Company, Inc.
  • Kyoto Kagaku Co., Ltd.
  • Medical-X
  • K.K. MedVision
  • Simulab Corporation
  • Limbs & Things Limited
  • Surgical Science Sweden AB
  • Mentice AB

Methodology

Loading
LOADING...